Clinical Trials Directory

Trials / Completed

CompletedNCT02153268

Filling Bone Defects/Voids With Autologous BonoFill For Maxillofacial Bone Regeneration

Phase I/II Open Label FIH Single Center Clinical Study Aimed to Evaluate the Safety and the Efficacy of BonoFill in Reconstructing the Bone.

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
11 (actual)
Sponsor
BonusBio Group Ltd · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Phase I/II open label first in human single center clinical study, is to evaluate the safety and the efficacy of BonoFill as bone filler containing the patient own (autologous) adipose tissue derived cells (HATDCs) in reconstructing the Bone Void in the maxillofacial area approximately 6 month follow up after implantation in the following two clinical indications: 1. Bone augmentation (e.g. sinus augmentation) 2. Bone grafting after removal of cysts from jaws

Detailed description

Primary endpoint: The implantation of BonoFill to the maxillary or mandible defect/void is safe under the following conditions: No chronic bone infection (Osteomyelitis); no significant changes in complete blood count (CBC) and in general health. Secondary endpoint: The implantation of BonoFill to the maxillary or mandible void is efficient under the following conditions: Following BonoFill implantation, the bone regeneration in the operated site was significantly accelerated. Also, the bone defects/voids were filled with a significant amount of bone tissue.

Conditions

Interventions

TypeNameDescription
PROCEDURESingle Arm - Liposuction procedure and BonoFill transplantation will be done for all subjects on studyLiposuction - will be performed on Visit 2, BonoFill will be based on subject's autologous Human Adipose Tissue Derived Cells (HATDCs). BonoFill Transplantation will be performed on Visit 6. BonoFill will be administrated to the subject in a single session at one tested cell dose.

Timeline

Start date
2014-02-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2014-06-03
Last updated
2017-01-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02153268. Inclusion in this directory is not an endorsement.